In this webinar, Dr. Jaroslaw Maciejewski (Cleveland Clinic) will discuss the diagnosis and treatment of PNH and MDS as well as the relationship between these diseases.
He will also talk about the biologic significance of the development of PNH clones in MDS and what this means as a prognosis. He will describe refractory anaemia MDS subgroups and hypoplastic MDS in particular.
As with all webinars, you will have time at the end for questions and answers.
This webinar is brought to you by Celgene, Achillion Pharmaceuticals and Genentech.